Mirion Technologies MIR Medical Segment — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mirion Technologies in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirion Technologies's medical segment — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirion Technologies's medical segment — capex?
- Mirion Technologies (MIR) reported medical segment — capex of $3.7M in Q1 2026.
- How has Mirion Technologies's medical segment — capex changed year-over-year?
- Mirion Technologies's medical segment — capex decreased by 21.3% year-over-year, from $4.7M to $3.7M.
- What is the long-term trend for Mirion Technologies's medical segment — capex?
- Over 3 years (2022 to 2025), Mirion Technologies's medical segment — capex has grown at a -3.7% compound annual growth rate (CAGR), from $22.6M to $20.2M.
- What does medical segment — capex mean?
- Reflects the cash outflows used by the Medical segment to acquire, upgrade, or maintain physical assets such as manufacturing equipment, research facilities, or technology infrastructure. This metric indicates the level of investment the company is committing to support the segment's long-term growth and operational capacity. High levels of expenditure often signal ongoing innovation or expansion efforts within the medical radiation oncology market.